The FDA has issued a warning about the possibility of a rare condition causing vision loss related to GLP-1 drugs, though risks remain small and data is mixed. Patients are urged to be aware of this potential side effect.
מקור: Ars Technica – All content — לכתבה המלאה
כתיבת תגובה